Commentary on “Complement C3 vs C5 inhibition in severe...

  • Main
  • 2020 / 10
  • Commentary on “Complement C3 vs C5 inhibition in severe...
Clinical Immunology 2020 / 10

Commentary on “Complement C3 vs C5 inhibition in severe COVID-19: Early clinical findings reveal differential biological efficacy” by D.C. Mastellos et al.

de Miranda Santos, Isabel Kinney Ferreira, de Barros Cardoso, Cristina Ribeiro
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
Clinical Immunology
DOI:
10.1016/j.clim.2020.108618
Date:
October, 2020
File:
PDF, 555 KB
2020
Conversion to is in progress
Conversion to is failed